John E. Imhoff - 06 Mar 2025 Form 4/A - Amendment Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role: Director, 10%+ Owner
Signature: /s/ John E. Imhoff
Issuer symbol: GTHP
Transactions as of: 06 Mar 2025
Transactions value $: $2,813,007
Form type: 4/A - Amendment
Filing time: 23 May 2025, 14:16:41 UTC
Date Of Original Report: 17 Apr 2025
Previous filing: 18 Feb 2025
Next filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Imhoff John E	Director, 10%+ Owner	5853 PEACHTREE CORNERS EAST, SUITE B, PEACHTREE CORNERS	/s/ John E. Imhoff	23 May 2025	0001348439

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHP	Preferred Series D Stock	Other		-300	-100%		0	06 Mar 2025	Direct	F1
transaction	GTHP	Common Stock	Other		+900K	+10.27%		9.66M	06 Mar 2025	Direct	F1
transaction	GTHP	Preferred Series C2 Stock	Other		-2.4K	-100%		0	06 Mar 2025	Direct	F2
transaction	GTHP	Common Stock	Other	$2.4M	+4.8M	+49.69%	$0.50	14.5M	06 Mar 2025	Direct
transaction	GTHP	Preferred Series C Stock	Purchase		+286			286	07 Mar 2025	Direct	F3
transaction	GTHP	Preferred Series C Stock	Other		-286	-100%		0	11 Mar 2025	Direct	F3
transaction	GTHP	Common Stock	Other	$286K	+2.26M	+15.62%	$0.13	16.7M	11 Mar 2025	Direct
transaction	GTHP	Preferred Series E Stock	Purchase		+150	+60%		400	13 Mar 2025	Direct	F4
transaction	GTHP	Common Stock	Purchase	$100K	+1M	+5.98%	$0.10	17.7M	18 Mar 2025	Direct	F5
transaction	GTHP	Common Stock	Purchase	$26.3K	+263K	+1.48%	$0.10	18M	18 Mar 2025	Direct	F6
transaction	GTHP	Common Stock	Other		+6.37K	+0.04%		18M	10 Apr 2025	Direct	F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHP	Warrants	Purchase		+1M			1M	18 Mar 2025	Common Stock	1M	$0.13	Direct	F5
transaction	GTHP	Warrants	Purchase		+263K	+26.31%		1.26M	18 Mar 2025	Common Stock	263K	$0.13	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.
F2	On March 6, 2025, Mr. Imhoff signed an exchange agreement to convert shares of Series C2 preferred stock at $0.50 conversion prices. For 2,400.75 Series C2 preferred shares, Mr. Imhoff received 4,801,500 common shares.
F3	On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.
F4	On March 13, 2025, for a purchase price of $30,000, Mr. Imhoff purchased 150 shares of Series E preferred stock from a third party. The shares have a conversion price of $0.25 and a stated value of $1,000.
F5	In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above.
F6	These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.
F7	These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.